T. Rowe Price Associates’s Axon Enterprise AXON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$335M Buy
788,636
+477,470
+153% +$248M 0.04% 335
2025
Q4
$177M Sell
311,166
-10,966
-3% -$6.8M 0.02% 500
2025
Q3
$231M Buy
322,132
+26,739
+9% +$20.3M 0.02% 427
2025
Q2
$245M Buy
295,393
+36,922
+14% +$25.1M 0.03% 392
2025
Q1
$136M Sell
258,471
-21,016
-8% -$12.3M 0.02% 504
2024
Q4
$166M Sell
279,487
-7,456
-3% -$4.06M 0.02% 467
2024
Q3
$115M Buy
286,943
+14,955
+5% +$5.16M 0.01% 538
2024
Q2
$80M Buy
271,988
+5,439
+2% +$1.62M 0.01% 594
2024
Q1
$83.4M Sell
266,549
-969
-0.4% -$269K 0.01% 589
2023
Q4
$69.1M Buy
267,518
+36,948
+16% +$8.33M 0.01% 615
2023
Q3
$45.9M Buy
230,570
+11,621
+5% +$2.29M 0.01% 709
2023
Q2
$42.7M Buy
218,949
+82,430
+60% +$17.1M 0.01% 748
2023
Q1
$30.7M Buy
136,519
+100,964
+284% +$20.1M ﹤0.01% 814
2022
Q4
$5.9M Buy
35,555
+98
+0.3% +$15.5K ﹤0.01% 1150
2022
Q3
$4.11M Buy
35,457
+1,386
+4% +$157K ﹤0.01% 1242
2022
Q2
$3.17M Sell
34,071
-131
-0.4% -$13.9K ﹤0.01% 1494
2022
Q1
$4.71M Buy
34,202
+2,081
+6% +$285K ﹤0.01% 1475
2021
Q4
$5.04M Sell
32,121
-1,728
-5% -$290K ﹤0.01% 1493
2021
Q3
$5.92M Buy
33,849
+107
+0.3% +$19.4K ﹤0.01% 1495
2021
Q2
$5.97M Sell
33,742
-1,864
-5% -$274K ﹤0.01% 1481
2021
Q1
$5.07M Sell
35,606
-3,116
-8% -$486K ﹤0.01% 1464
2020
Q4
$4.75M Sell
38,722
-780
-2% -$89.5K ﹤0.01% 1452
2020
Q3
$3.58M Buy
39,502
+838
+2% +$72.9K ﹤0.01% 1443
2020
Q2
$3.79M Sell
38,664
-7,507
-16% -$607K ﹤0.01% 1418
2020
Q1
$3.27M Sell
46,171
-56,651
-55% -$4.24M ﹤0.01% 1400
2019
Q4
$7.54M Sell
102,822
-26,887
-21% -$1.7M ﹤0.01% 1348
2019
Q3
$7.37M Sell
129,709
-3,524
-3% -$222K ﹤0.01% 1329
2019
Q2
$8.55M Sell
133,233
-15,184
-10% -$990K ﹤0.01% 1342
2019
Q1
$8.07M Buy
148,417
+399
+0.3% +$20.4K ﹤0.01% 1348
2018
Q4
$6.48M Sell
148,018
-10,293
-7% -$534K ﹤0.01% 1377
2018
Q3
$10.8M Buy
158,311
+3,693
+2% +$249K ﹤0.01% 1356
2018
Q2
$9.77M Sell
154,618
-6,834
-4% -$370K ﹤0.01% 1348
2018
Q1
$6.35M Buy
161,452
+102
+0.1% +$3.18K ﹤0.01% 1398
2017
Q4
$4.28M Buy
161,350
+6,890
+4% +$165K ﹤0.01% 1450
2017
Q3
$3.5M Buy
154,460
+7,000
+5% +$164K ﹤0.01% 1482
2017
Q2
$3.71M Buy
147,460
+32,426
+28% +$793K ﹤0.01% 1451
2017
Q1
$2.62M Hold
115,034
﹤0.01% 1516
2016
Q4
$2.79M Buy
115,034
+75,521
+191% +$1.86M ﹤0.01% 1501
2016
Q3
$1.13M Hold
39,513
﹤0.01% 1697
2016
Q2
$983K Sell
39,513
-554,937
-93% -$11.5M ﹤0.01% 1714
2016
Q1
$11.7M Buy
594,450
+14,116
+2% +$242K ﹤0.01% 1235
2015
Q4
$10M Sell
580,334
-64,150
-10% -$1.28M ﹤0.01% 1284
2015
Q3
$14.2M Buy
644,484
+240,339
+59% +$6.35M ﹤0.01% 1211
2015
Q2
$13.5M Buy
404,145
+373,985
+1,240% +$11.7M ﹤0.01% 1264
2015
Q1
$727K Hold
30,160
﹤0.01% 1838
2014
Q4
$799K Hold
30,160
﹤0.01% 1778
2014
Q3
$466K Hold
30,160
﹤0.01% 1966
2014
Q2
$401K Sell
30,160
-8,000
-21% -$119K ﹤0.01% 2043
2014
Q1
$698K Buy
38,160
+4,300
+13% +$76.9K ﹤0.01% 1792
2013
Q4
$538K Sell
33,860
-9,900
-23% -$161K ﹤0.01% 1870
2013
Q3
$652K Hold
43,760
﹤0.01% 1795
2013
Q2
$373K Buy
+43,760
New +$383K ﹤0.01% 1984

Other funds holding AXON

T. Rowe Price Associates's AXON Position: Q1 2026 in Review

T. Rowe Price Associates increased its Axon Enterprise (AXON) stake by 153% in Q1 2026, buying an estimated $248M and bringing the position to 788,636 shares worth $335M. The position accounts for 0.04% of the portfolio, ranked #335.

T. Rowe Price Associates first reported a position in AXON in Q2 2013 and has held it in 52 quarters since. 1,048 funds tracked by Wall St. Rank hold AXON as of Q1 2026.

  • T. Rowe Price Associates held 788,636 shares of Axon Enterprise worth $335M as of Q1 2026.
  • T. Rowe Price Associates bought 477,470 Axon Enterprise shares in Q1 2026, an estimated $248M.
  • Axon Enterprise made up 0.04% of T. Rowe Price Associates's portfolio in Q1 2026, its #335 holding.
  • T. Rowe Price Associates first reported a position in Axon Enterprise in Q2 2013 and has held it in 52 quarters since.
  • 1,048 funds tracked by Wall St. Rank held Axon Enterprise as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.